Acorda, Merz in “Stalking Horse” Asset Purchase Pact After Chapter 11

 Acorda Files for Voluntary Chapter 11 Protection to Facilitate Orderly Sale

Acorda Enters into a Restructuring Support Agreement with over 90% of the Secured Convertible Noteholders

Patient Access to INBRIJA® (levodopa inhalation powder) and AMPYRA® (dalfampridine) to Continue Uninterrupted

Additional information about the bankruptcy cases is available by calling the Company's Restructuring Information Line at (844) 712-1917 within the U.S., or (646) 777-2412 outside the U.S. Information is also available at https://cases.ra.kroll.com/Acorda. Additional information may also be found in our public reports filed with the Securities and Exchange Commission.

https://www.businesswire.com/news/home/20240401939079/en/